老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Spectre Acquisition Corp
1.63
0.0000
成交量：
- -
成交额：
- -
市值：
2,245.10万
市盈率：
-0.83
高：
1.63
开：
1.63
低：
1.63
收：
1.63
52周最高：
5.52
52周最低：
0.6500
股本：
1,377.36万
流通股本：
413.60万
量比：
- -
换手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-1.9700
每股收益(LYR):
-1.6655
净资产收益率：
-36.97%
总资产收益率：
-28.97%
市净率：
2.13
市盈率(LYR):
-0.98
数据加载中...
总览
公司
新闻资讯
公告
2021/06/10
重要事件披露
8-K - Current report
2021/05/13
重要事件披露
8-K - Current report
2021/05/10
季度报告
10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03
重要事件披露
8-K - Current report
2021/04/16
重要事件披露
8-K - Current report
2021/04/13
重要事件披露
8-K - Current report
2021/03/25
年度报告
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/05
重要事件披露
8-K - Current report
2021/02/25
超过5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25
超过5%披露
SC 13D - General statement of acquisition of beneficial ownership
2021/02/18
重要事件披露
8-K - Current report
2021/02/17
超过5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16
超过5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03
重要事件披露
8-K - Current report
2021/01/25
重要事件披露
8-K - Current report
2021/01/19
重要事件披露
8-K - Current report
2021/01/11
重要事件披露
8-K - Current report
2021/01/05
超过5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/20
重要事件披露
8-K - Current report
2020/11/13
季度报告
10-Q - Quarterly report [Sections 13 or 15(d)]
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SPEX/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SPEX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","market":"US","secType":"STK","nameCN":"Spectre Acquisition Corp","latestPrice":1.63,"timestamp":1584043200000,"preClose":1.63,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":4136026,"shares":13773600,"eps":-1.97,"marketStatus":"交易中","change":0,"latestTime":"02-25 14:49:59 EST","open":1.63,"high":1.63,"low":1.63,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.97,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"AIKI","executeDate":"2020-03-13"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.63,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","floatShares":4136026,"roa":"-28.97%","roe":"-36.97%","lyrEps":-1.665494,"shares":13773600,"dividePrice":0,"high":1.63,"amplitude":0,"preClose":1.63,"low":1.63,"week52Low":0.65,"pbRate":"2.13","week52High":5.52,"institutionHeld":0.0903,"latestPrice":1.63,"eps":-1.97,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.97,"open":1.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPEX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-02-01","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1612155600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-10","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1604984400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-05-14","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1589428800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-03-13","symbol":"SPEX","oldSymbol":"SPEX","newSymbol":"AIKI","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584072000000},{"market":"US","date":"2020-02-03","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1580706000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPEX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPEX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"SPEX\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12883629","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021031800-SPEX","pdf_url":null,"pub_time":1623254400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/0001213900-21-031800-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AIKI 2021 LD MICRO INVITATIONAL XI PRESENTATION DECK, DATED JUNE 10, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513ex99-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea142513ex99-1_aikido.htm","type":"EX-99.1","id":"NTFILE3oo2mF76gv6eNi5y","market":"us","size":19266},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea142513-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5u8WsQGXEuaFRAD8","market":"us","size":29068},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEEaaguf4zqvnSZaQr","market":"us","size":74902},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEEEGb16VLahn44RkA","market":"us","size":181200},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEDAkSeW2Ya2eCK5YA","market":"us","size":138834},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILEDq3eA5osx9xoreKF","market":"us","size":179332},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEAeLZM8Fn2TSfdGKS","market":"us","size":217409},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE65szotZqaUxHDvsh","market":"us","size":225046},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE7yxMqkQU2wx3rneC","market":"us","size":156611},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE9ZFv4evqs2hbJSde","market":"us","size":189506},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE3Fu8yysFN6kfvikB","market":"us","size":224152},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEBtvHCYutUhjvfSs1","market":"us","size":181544},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEGqb9Ge58sM4F7sqt","market":"us","size":221810},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE9WrVaR6htJTio85U","market":"us","size":193360},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE3m31WrmUMTBMPXYW","market":"us","size":188517},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEBrBXnXQTPqP1x6qT","market":"us","size":71313}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-06-10 00:00","pubTimestamp":1623254400,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883624","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025950-SPEX","pdf_url":null,"pub_time":1620835200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/0001213900-21-025950-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BENZINGA GLOBAL SMALL CAP CONFERENCE PRESENTATION, DATED MAY 13, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea140763ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEvXazQCuxLLyWDsgr","market":"us","size":15316},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea140763-8k_aikidopharma.htm","type":"8-K","id":"NTFILEDpASpEWEbV7AZbq6","market":"us","size":19340},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6DmmgsRd1vH2MgRX","market":"us","size":101978},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE27JBAUL45Asd5zPJ","market":"us","size":251316},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILE7TYsZ32i4XgwKJHi","market":"us","size":200762},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE9aSzqY1drfoKEUS5","market":"us","size":245231},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILE79Kyg4s6t7E4BCZk","market":"us","size":284116},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE5ad1vp1SEH6Sx5Nk","market":"us","size":211274},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEHy6DCwQJ2fdGaDVS","market":"us","size":260371},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILEDLokJ9R216UUrHP9","market":"us","size":249345},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILEAwGjkEQt4oogrTxQ","market":"us","size":304202},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEAxCW9uqRtEAyYg3A","market":"us","size":260499},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEBmQGYqXEFy4NjbED","market":"us","size":103852}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-13 00:00","pubTimestamp":1620835200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883602","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025331-SPEX","pdf_url":null,"pub_time":1620576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/0001213900-21-025331-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[{"id":98436,"name":"Condensed Consolidated Balance Sheets","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98437,"name":"Condensed Consolidated Balance Sheets (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98438,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98439,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98440,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R6.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98441,"name":"Condensed Consolidated Statements of Cash Flows","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R7.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度报告","pubTime":"2021-05-10 00:00","pubTimestamp":1620576000,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021024121-SPEX","pdf_url":null,"pub_time":1619971200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021024121/0001213900-21-024121-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-03 00:00","pubTimestamp":1619971200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883596","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021934-SPEX","pdf_url":null,"pub_time":1618502400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/0001213900-21-021934-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXCLUSIVE PATENT LICENSE AGREEMENT BY AND AMONG SILO PHARMA INC., A DELAWARE COR","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-1_alkidipharm.htm","primary":true,"translateUrl":null,"linkName":"ea139554ex10-1_alkidipharm.htm","type":"EX-10.1","id":"NTFILE4rTMbUWpDsziDjSV","market":"us","size":111212},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554-8k_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554-8k_alkidipharm.htm","type":"8-K","id":"NTFILE2hpS2YC9cdVn7BpQ","market":"us","size":23674},{"description":"AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED APRIL 12, 2021.","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-2_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554ex10-2_alkidipharm.htm","type":"EX-10.2","id":"NTFILEienE3zGfGP5SBtgT","market":"us","size":124955}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-16 00:00","pubTimestamp":1618502400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：订立重要最终协议；第5.02项：董事或某些高级职员离任；选举董事；某些主席团成员的任命：某些主席团成员的补偿安排；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883599","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021415-SPEX","pdf_url":null,"pub_time":1618243200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/0001213900-21-021415-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER OF MARCUM LLP, TO THE SECURITIES AND EXCHANGE COMMISSION DATED APRIL 12,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404ex16-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea139404ex16-1_aikido.htm","type":"EX-16.1","id":"NTFILEGeDZsQHK1dHwzkZH","market":"us","size":3189},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404-8k_aikido.htm","primary":false,"translateUrl":null,"linkName":"ea139404-8k_aikido.htm","type":"8-K","id":"NTFILE8viVqbniPXcWyZL6","market":"us","size":21086}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-13 00:00","pubTimestamp":1618243200,"title_zh":"8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01项：注册人注册会计师变更；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883621","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021017738-SPEX","pdf_url":null,"pub_time":1616601600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"SPEX","title":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/0001213900-21-017738-index.htm","us_notice_code":"Form 10-K","us_title_en":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10k2020_aikidopharma.htm","type":"10-K","id":"NTFILE7BeoeZnyytJVEWqj","market":"us","size":1018017},{"description":"LIST OF SUBSIDIARIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex21-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex21-1_aikido.htm","type":"EX-21.1","id":"NTFILEDGoutwNn8rPeCrPy","market":"us","size":2637},{"description":"INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex23-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex23-1_aikido.htm","type":"EX-23.1","id":"NTFILEAeQ654jz4Aah1j4u","market":"us","size":2073},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILE6Yn81V1Axai3C7Mt","market":"us","size":14625},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILE8QKjET1csJvVz72T","market":"us","size":7024},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEELvyBjNhwzrmYMoz","market":"us","size":7209},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE5K6a19yGpZq6d1Z2","market":"us","size":9017}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2021-03-25 00:00","pubTimestamp":1616601600,"title_zh":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883630","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021013614-SPEX","pdf_url":null,"pub_time":1614873600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/0001213900-21-013614-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"INVESTOR PRESENTATION, DATED MARCH 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036ex99-1_aikidopharm.htm","primary":true,"translateUrl":null,"linkName":"ea137036ex99-1_aikidopharm.htm","type":"EX-99.1","id":"NTFILE4pij9WsJtM44esbd","market":"us","size":20791},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036-8k_aikidopharm.htm","primary":false,"translateUrl":null,"linkName":"ea137036-8k_aikidopharm.htm","type":"8-K","id":"NTFILEDLLHFw31oiAsqxmB","market":"us","size":18837},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE3qMAZntttuiFgLDF","market":"us","size":62678},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEDhZ5RZeuZ5ALWSXx","market":"us","size":120946},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEGJ63ZggoiHrgNhsG","market":"us","size":138569},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE4cYx2QaYGwSScdRz","market":"us","size":167764},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILECbafdTb67tbKRds3","market":"us","size":149916},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEDyUBktFRG2dXu4Gt","market":"us","size":136336},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE3dUFr5z9NKhFGG6A","market":"us","size":185503},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE4H1gT3XmyM7u3xYT","market":"us","size":115928},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE9AT95imrnZfT1FuR","market":"us","size":164385},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE9oja1kLyFHGQcdfx","market":"us","size":158676},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEHA83cdn2qxrKUKdC","market":"us","size":146019},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILEGaTcQpwEicj5iYFJ","market":"us","size":161590},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE2K7BheZAGKmHNAT7","market":"us","size":106514},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEDG3AC6Zmprn32ZrB","market":"us","size":160789},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_015.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_015.jpg","type":"GRAPHIC","id":"NTFILE4qqYRSqCuu2tB4Px","market":"us","size":54726}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-03-05 00:00","pubTimestamp":1614873600,"title_zh":"8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883613","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921027944-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/0001104659-21-027944-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/tm217745d5_sc13g.htm","primary":true,"translateUrl":null,"linkName":"tm217745d5_sc13g.htm","type":"SC 13G","id":"NTFILEEfYjx4WYTo6d3kZi","market":"us","size":67296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883601","market":"us","labels":[],"media":"sec.gov","original_id":"AN151316221000027-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D - General statement of acquisition of beneficial ownership","symbol":"SPEX","title":"SC 13D - General statement of acquisition of beneficial ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/0001513162-21-000027-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/sc_13d.htm","primary":true,"translateUrl":null,"linkName":"sc_13d.htm","type":"SC 13D","id":"NTFILEHEjxNVSwNYNG6b1J","market":"us","size":85177}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883632","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021010360-SPEX","pdf_url":null,"pub_time":1613577600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/0001213900-21-010360-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDED AND RESTATED UNDERWRITING AGREEMENT BY AND BETWEEN THE COMPANY AND H.C.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex1-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea135980ex1-1_aikidopharma.htm","type":"EX-1.1","id":"NTFILEDr3kKQEYhUd3aVU7","market":"us","size":210347},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980-8k_aikidopharma.htm","type":"8-K","id":"NTFILEG7p9a8ecT8ZsiKxf","market":"us","size":29618},{"description":"OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex5-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex5-1_aikidopharma.htm","type":"EX-5.1","id":"NTFILE5oFcRtLim85w66AM","market":"us","size":7284},{"description":"FORM OF UNDERWRITER'S WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex10-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex10-1_aikidopharma.htm","type":"EX-10.1","id":"NTFILE2MXkatVHCfrFvBCs","market":"us","size":103814},{"description":"PRESS RELEASE DATED FEBRUARY 16, 2021","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex99-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEDT6QB6LSQ5dunAcg","market":"us","size":10750},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEDiMeCrJjoixDgESE","market":"us","size":3760},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEC8MuLQuyG6ixd1mc","market":"us","size":5296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-18 00:00","pubTimestamp":1613577600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：订立重要最终协议；第3.02项：未登记出售权益性证券；项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883616","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021009748-SPEX","pdf_url":null,"pub_time":1613491200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/0001213900-21-009748-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/ea135498-13gaikido_hoththera.htm","primary":true,"translateUrl":null,"linkName":"ea135498-13gaikido_hoththera.htm","type":"SC 13G","id":"NTFILEYbWEbNH3kcPoRNsa","market":"us","size":47708}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-17 00:00","pubTimestamp":1613491200,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883610","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921023188-SPEX","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921023188/0001104659-21-023188-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883612","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021006449-SPEX","pdf_url":null,"pub_time":1612281600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021006449/0001213900-21-006449-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-03 00:00","pubTimestamp":1612281600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：订立重要最终协议；项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883623","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021004059-SPEX","pdf_url":null,"pub_time":1611504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/0001213900-21-004059-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 22, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133854ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILE8imYnRMsHP3c5QXX","market":"us","size":7776},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea133854-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5iMd3v3B3rHop5by","market":"us","size":20069},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAPDcGCUW89Mdgo59","market":"us","size":10738}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-25 00:00","pubTimestamp":1611504000,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他项目；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883607","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021002859-SPEX","pdf_url":null,"pub_time":1610985600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/0001213900-21-002859-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/ea133558-8k_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133558-8k_aikidopharma.htm","type":"8-K","id":"NTFILEB2sVx5zWHfA6XoXY","market":"us","size":26683}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-19 00:00","pubTimestamp":1610985600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883595","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021001460-SPEX","pdf_url":null,"pub_time":1610294400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021001460/0001213900-21-001460-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-11 00:00","pubTimestamp":1610294400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：订立重要最终协议；第3.02项：未登记出售权益性证券；第5.03项：修改公司章程或章程细则；会计年度的变化；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883615","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561021000028-SPEX","pdf_url":null,"pub_time":1609776000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000153561021000028/0001535610-21-000028-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-01-05 00:00","pubTimestamp":1609776000,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883625","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020038376-SPEX","pdf_url":null,"pub_time":1605801600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/0001213900-20-038376-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276ex99-1_alkido.htm","primary":true,"translateUrl":null,"linkName":"ea130276ex99-1_alkido.htm","type":"EX-99.1","id":"NTFILEETiFdX9GjpuUCqvr","market":"us","size":19840},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276-8k_alkido.htm","primary":false,"translateUrl":null,"linkName":"ea130276-8k_alkido.htm","type":"8-K","id":"NTFILEDu3qVxAAqqkjJQwb","market":"us","size":38995},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGoFgALtso4AQUqPo","market":"us","size":6183}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2020-11-20 00:00","pubTimestamp":1605801600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目5.07：将事项提交证券持有人表决；项目9.01：财务报表和证物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883614","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020036928-SPEX","pdf_url":null,"pub_time":1605196800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/0001213900-20-036928-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10q0920_aikidopharma.htm","type":"10-Q","id":"NTFILE6s7XjJmXFxE4cwSi","market":"us","size":469655},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILEESjtaLima2zhzsog","market":"us","size":15931},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILECsjdozcRnptbQdmf","market":"us","size":6973}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[{"id":98442,"name":"Condensed Consolidated Balance Sheets (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98443,"name":"Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98444,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98445,"name":"Consolidated Statements of Changes in Stockholders' Equity (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98446,"name":"Condensed Consolidated Statements of Cash Flows (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R6.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度报告","pubTime":"2020-11-13 00:00","pubTimestamp":1605196800,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":149,"code":"91000000","status":"200"}]}}